ACE and diabetes mellitus: The objective of our study was to systematically review all randomised, placebo-controlled trials that had evaluated to what extent the ACE gene insertion/deletion polymorphism influences treatment effects of ACE inhibitors on any surrogate and on any clinically relevant parameters in patients with cardiovascular diseases, diabetes, renal transplantation and/or renal disease.